Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustion.
about
The role of regulatory T cells in nervous system pathologies.Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma.Targeting tumour microenvironment by tyrosine kinase inhibitor.Combinatorial effects of VEGFR kinase inhibitor axitinib and oncolytic virotherapy in mouse and human glioblastoma stem-like cell models.Turn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression
P2860
Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustion.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Disease progression in recurre ...... numbers and T cell exhaustion.
@en
type
label
Disease progression in recurre ...... numbers and T cell exhaustion.
@en
prefLabel
Disease progression in recurre ...... numbers and T cell exhaustion.
@en
P2093
P2860
P1476
Disease progression in recurre ...... numbers and T cell exhaustion
@en
P2093
Brenda De Keersmaecker
Daphné Benteyn
Joeri L Aerts
Kris Thielemans
Sarah K Maenhout
Stephanie Du Four
P2860
P2888
P304
P356
10.1007/S00262-016-1836-3
P577
2016-04-20T00:00:00Z
P6179
1001727097